A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART

Use of Amphetamine-type Stimulants & Its Relationship With HIV Incidence and Antiretroviral Adherence Among MSM and TG

NCT03198962 ·Status: COMPLETED

Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised

NCT00238459 ·Status: COMPLETED

A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS

NCT00002285 ·Status: COMPLETED ·Phase: NA

A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone

NCT00000870 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3

NCT00000756 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

NCT00052182 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption

NCT04340596 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of the Safety and Antiretroviral Activity of 3BNC117

NCT02588586 ·Status: COMPLETED ·Phase: PHASE2

Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452

NCT00006495 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine

NCT00751595 ·Status: COMPLETED ·Phase: PHASE2

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

NCT00058734 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

NCT00001131 ·Status: COMPLETED ·Phase: NA

A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients

NCT00000824 ·Status: TERMINATED ·Phase: NA

Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs

NCT00050921 ·Status: COMPLETED ·Phase: NA

A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons

NCT00001060 ·Status: COMPLETED ·Phase: PHASE1

A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease

NCT00205231 ·Status: COMPLETED ·Phase: NA

Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV

NCT00329251 ·Status: COMPLETED ·Phase: PHASE4

A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected Patients

NCT00001282 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine

NCT00482027 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3

NCT00000755 ·Status: COMPLETED ·Phase: PHASE1

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

NCT00001041 ·Status: COMPLETED ·Phase: PHASE1

Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV

NCT00021762 ·Status: WITHDRAWN ·Phase: PHASE2

A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection

NCT00000852 ·Status: COMPLETED ·Phase: NA

A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children

NCT00000827 ·Status: COMPLETED ·Phase: PHASE1

Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult Twins

NCT01054872 ·Status: COMPLETED ·Phase: PHASE1